BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 288 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $155 | +369.7% | 1,925 | +430.3% | 0.00% | – |
Q1 2024 | $33 | -19.5% | 363 | -7.6% | 0.00% | – |
Q4 2023 | $41 | +10.8% | 393 | +16.6% | 0.00% | – |
Q3 2023 | $37 | +2.8% | 337 | 0.0% | 0.00% | – |
Q2 2023 | $36 | -21.7% | 337 | -8.9% | 0.00% | – |
Q1 2023 | $46 | -87.5% | 370 | -84.9% | 0.00% | -100.0% |
Q4 2022 | $368 | -99.9% | 2,450 | +14.1% | 0.00% | +50.0% |
Q3 2022 | $290,000 | +491.8% | 2,147 | +554.6% | 0.00% | – |
Q2 2022 | $49,000 | -86.2% | 328 | -84.2% | 0.00% | -100.0% |
Q1 2022 | $355,000 | -29.6% | 2,080 | +6.4% | 0.00% | -33.3% |
Q4 2021 | $504,000 | -2.1% | 1,955 | +3.6% | 0.00% | 0.0% |
Q3 2021 | $515,000 | +1371.4% | 1,887 | +1101.9% | 0.00% | – |
Q2 2021 | $35,000 | +118.8% | 157 | +5.4% | 0.00% | – |
Q1 2021 | $16,000 | +60.0% | 149 | +19.2% | 0.00% | – |
Q4 2020 | $10,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $11,947,443 | 19.99% |
Quinn Opportunity Partners LLC | 683,287 | $54,908,943 | 6.24% |
Krensavage Asset Management, LLC | 132,293 | $10,631 | 4.88% |
Crocodile Capital Partners GmbH | 29,586 | $2,377,531 | 3.78% |
ALTRINSIC GLOBAL ADVISORS LLC | 676,219 | $54,340,958 | 2.42% |
FLOSSBACH VON STORCH AG | 4,379,483 | $351,935,254 | 1.48% |
Systrade AG | 10,000 | $803,600 | 1.38% |
HARDING LOEVNER LP | 2,926,761 | $235,224,417 | 1.30% |
CenterBook Partners LP | 206,234 | $16,572,964 | 1.03% |
SECTORAL ASSET MANAGEMENT INC | 27,265 | $2,191,015 | 0.89% |